Bone morphogenetic protein receptors and bone morphogenetic protein signaling are controlled by tumor necrosis factor-α in human bone cells

International Journal of Biochemistry and Cell Biology

Volumn 38, Issue 10, 2006, Pages 1794-1807

  Singhatanadgit, W ^a   Salih, V ^a   Olsen, I ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Bone cells; Bone morphogenetic protein receptor; Bone morphogenetic protein signaling; Shedding; Tumor necrosis factor

Indexed keywords

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN RECEPTOR; BONE MORPHOGENETIC PROTEIN RECEPTOR 2; BONE MORPHOGENETIC PROTEIN RECEPTOR IA; BONE MORPHOGENETIC PROTEIN RECEPTOR IB; CYTOKINE; MEMBRANE ANTIGEN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; OSTEOCALCIN; SMAD1 PROTEIN; SMAD5 PROTEIN; SMAD8 PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; BONE CELL; CELL CULTURE; CELL DIFFERENTIATION; CELL FUNCTION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOTHESIS; OSTEOBLAST; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SUPERNATANT;

ANTIGENS; BONE AND BONES; BONE MORPHOGENETIC PROTEIN RECEPTORS; BONE MORPHOGENETIC PROTEINS; CELL DIFFERENTIATION; CELLS, CULTURED; DOWN-REGULATION; GENE EXPRESSION REGULATION; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; OSTEOCLASTS; OSTEOCYTES; PHOSPHORYLATION; PROTEIN BIOSYNTHESIS; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA; UBIQUITIN-PROTEIN LIGASES;

EID: 33745332708     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2006.05.005     Document Type: Article

References (84)

1. Anders R.A., Arline S.L., Dore J.J., and Leof E.B. Distinct endocytic responses of heteromeric and homomeric transforming growth factor beta receptors. Molecular Biology of the Cell 8 (1997) 2133-2143
2. Aoki H., Fujii M., Imamura T., Yagi K., Takehara K., Kato M., et al. Synergistic effects of different bone morphogenetic protein type I receptors on alkaline phosphatase induction. Journal of Cell Science 114 (2001) 1483-1489
3. Black R.A., Rauch C.T., Kozlosky C.J., Peschon J.J., Slack J.L., Wolfson M.F., et al. A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature 385 (1997) 729-733
4. Boden S.D., Kang J., Sandhu H., and Heller J.G. Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: A prospective, randomized clinical pilot trial: 2002 Volvo Award in clinical studies. Spine 27 (2002) 2662-2673
5. Bostrom M.P., and Camacho N.P. Potential role of bone morphogenetic proteins in fracture healing. Clinical Orthopaedics (1998) S274-S282
6. Chen D., Ji X., Harris M.A., Feng J.Q., Karsenty G., Celeste A.J., et al. Differential roles for bone morphogenetic protein (BMP) receptor type IB and IA in differentiation and specification of mesenchymal precursor cells to osteoblast and adipocyte lineages. Journal of Cell Biology 142 (1998) 295-305
7. Chen D., Zhao M., Harris S.E., and Mi Z. Signal transduction and biological functions of bone morphogenetic proteins. Frontiers in Bioscience 9 (2004) 349-358
8. Chen G., and Goeddel D.V. TNF-R1 signaling: A beautiful pathway. Science 296 (2002) 1634-1635
9. Cheng H., Jiang W., Phillips F.M., Haydon R.C., Peng Y., Zhou L., et al. Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs). Journal of Bone and Joint Surgery 85-A (2003) 1544-1552
10. Cheng S.L., Lou J., Wright N.M., Lai C.F., Avioli L.V., and Riew K.D. In vitro and in vivo induction of bone formation using a recombinant adenoviral vector carrying the human BMP-2 gene. Calcified Tissue International 68 (2001) 87-94
11. Chentoufi J., Hott M., Lamblin D., Buc-Caron M.H., Marie P.J., and Kellermann O. Kinetics of in vitro mineralization by an osteogenic clonal cell line (C1) derived from mouse teratocarcinoma. Differentiation 53 (1993) 181-189
12. Dale L., and Jones C.M. BMP signalling in early Xenopus development. Bioessays 21 (1999) 751-760
13. Dello S.P., and Rovida E. Transmodulation of cell surface regulatory molecules via ectodomain shedding. Biological Chemistry 383 (2002) 69-83
14. Di Guglielmo G.M., Le Roy C., Goodfellow A.F., and Wrana J.L. Distinct endocytic pathways regulate TGF-beta receptor signalling and turnover. Nature Cell Biology 5 (2003) 410-421
15. Doglioli P., and Scortecci G. Characterization of endosteal osteoblasts isolated from human maxilla and mandible: An experimental system for biocompatibility tests. Cytotechnology 7 (1991) 39-48
16. Dore Jr. J.J., Yao D., Edens M., Garamszegi N., Sholl E.L., and Leof E.B. Mechanisms of transforming growth factor-beta receptor endocytosis and intracellular sorting differ between fibroblasts and epithelial cells. Molecular Biology of the Cell 12 (2001) 675-684
17. Ebara S., and Nakayama K. Mechanism for the action of bone morphogenetic proteins and regulation of their activity. Spine 27 (2002) S10-S15
18. Franchimont N., Lambert C., Huynen P., Ribbens C., Relic B., Chariot A., et al. Interleukin-6 receptor shedding is enhanced by interleukin-1beta and tumor necrosis factor alpha and is partially mediated by tumor necrosis factor alpha-converting enzyme in osteoblast-like cells. Arthritis and Rheumatism 52 (2005) 84-93
19. Garton K.J., Gough P.J., Philalay J., Wille P.T., Blobel C.P., Whitehead R.H., et al. Stimulated shedding of vascular cell adhesion molecule 1 (VCAM-1) is mediated by tumor necrosis factor-alpha-converting enzyme (ADAM 17). Journal of Biological Chemistry 278 (2003) 37459-37464
20. Gerstenfeld L.C., Chipman S.D., Glowacki J., and Lian J.B. Expression of differentiated function by mineralizing cultures of chicken osteoblasts. Developmental Biology 122 (1987) 49-60
21. Gilbert L., He X., Farmer P., Boden S., Kozlowski M., Rubin J., et al. Inhibition of osteoblast differentiation by tumor necrosis factor-alpha. Endocrinology 141 (2000) 3956-3964
22. Gilbert L., He X., Farmer P., Rubin J., Drissi H., van Wijnen A.J., et al. Expression of the osteoblast differentiation factor RUNX2 (Cbfa1/AML3/Pebp2alpha A) is inhibited by tumor necrosis factor-alpha. Journal of Biological Chemistry 277 (2002) 2695-2701
23. Hanneken A. Structural characterization of the circulating soluble FGF receptors reveals multiple isoforms generated by secretion and ectodomain shedding. FEBS Letters 489 (2001) 176-181
24. Hayes S., Chawla A., and Corvera S. TGF beta receptor internalization into EEA1-enriched early endosomes: Role in signaling to Smad2. Journal of Cell Biology 158 (2002) 1239-1249
25. Horiguchi M., Akiyama H., Ito H., Shigeno C., and Nakamura T. Tumour necrosis factor-alpha up-regulates the expression of BMP-4 mRNA but inhibits chondrogenesis in mouse clonal chondrogenic EC cells, ATDC5. Cytokine 12 (2000) 526-530
26. Hu Q., Dey A.L., Yang Y., Shen Y., Jilani I.B., Estey E.H., et al. Soluble vascular endothelial growth factor receptor 1, and not receptor 2, is an independent prognostic factor in acute myeloid leukemia and myelodysplastic syndromes. Cancer 100 (2004) 1884-1891
27. Ito H., Akiyama H., Shigeno C., and Nakamura T. Noggin and bone morphogenetic protein-4 coordinately regulate the progression of chondrogenic differentiation in mouse clonal EC cells, ATDC5. Biochemical and Biophysical Research Communications 260 (1999) 240-244
28. Izumi Y., Hirose T., Tamai Y., Hirai S., Nagashima Y., Fujimoto T., et al. An atypical PKC directly associates and colocalizes at the epithelial tight junction with ASIP, a mammalian homologue of Caenorhabditis elegans polarity protein PAR-3. Journal of Cell Biology 143 (1998) 95-106
29. Johnson G.L., and Vaillancourt R.R. Sequential protein kinase reactions controlling cell growth and differentiation. Current Opinion in Cell Biology 6 (1994) 230-238
30. Jones S.A., Horiuchi S., Topley N., Yamamoto N., and Fuller G.M. The soluble interleukin 6 receptor: Mechanisms of production and implications in disease. The FASEB Journal 15 (2001) 43-58
31. Jortikka L., Laitinen M., Lindholm T.S., and Marttinen A. Internalization and intracellular processing of bone morphogenetic protein (BMP) in rat skeletal muscle myoblasts (L6). Cellular Signalling 9 (1997) 47-51
32. Kaneki H., Guo R., Chen D., Yao Z., Schwarz E.M., Zhang Y.E., et al. Tumor necrosis factor promotes Runx2 degradation through up-regulation of Smurf1 and Smurf2 in osteoblasts. Journal of Biological Chemistry 281 (2006) 4326-4333
33. Kotake S., Sato K., Kim K.J., Takahashi N., Udagawa N., Nakamura I., et al. Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation. Journal of Bone and Mineral Research 11 (1996) 88-95
34. Lieberman J.R., Daluiski A., and Einhorn T.A. The role of growth factors in the repair of bone. Biology and clinical applications. Journal of Bone and Joint Surgery 84-A (2002) 1032-1044
35. Liu F., Ventura F., Doody J., and Massague J. Human type II receptor for bone morphogenic proteins (BMPs): Extension of the two-kinase receptor model to the BMPs. Molecular Cell Biology 15 (1995) 3479-3486
36. Lukic I.K., Grcevic D., Kovacic N., Katavic V., Ivcevic S., Kalajzic I., et al. Alteration of newly induced endochondral bone formation in adult mice without tumour necrosis factor receptor 1. Clinical and Experimental Immunology 139 (2005) 236-244
37. Lum L., Wong B.R., Josien R., Becherer J.D., Erdjument-Bromage H., Schlondorff J., et al. Evidence for a role of a tumor necrosis factor-alpha (TNF-alpha)-converting enzyme-like protease in shedding of TRANCE, a TNF family member involved in osteoclastogenesis and dendritic cell survival. Journal of Biological Chemistry 274 (1999) 13613-13618
38. Madge L.A., and Pober J.S. TNF signaling in vascular endothelial cells. Experimental and Molecular Pathology 70 (2001) 317-325
39. Massague J., and Chen Y.G. Controlling TGF-beta signaling. Genes & Development 14 (2000) 627-644
40. Mehler M.F., Mabie P.C., Zhang D., and Kessler J.A. Bone morphogenetic proteins in the nervous system. Trends in Neurosciences 20 (1997) 309-317
41. Miyazono K. Signal transduction by bone morphogenetic protein receptors: Functional roles of Smad proteins. Bone 25 (1999) 91-93
42. Miyazono K., Maeda S., and Imamura T. BMP receptor signaling: Transcriptional targets, regulation of signals, and signaling cross-talk. Cytokine & Growth Factor Reviews 16 (2005) 251-263
43. Muller-Newen G., Kohne C., and Heinrich P.C. Soluble receptors for cytokines and growth factors. International Archives of Allergy and Immunology 111 (1996) 99-106
44. Muller-Newen G., Kohne C., Keul R., Hemmann U., Muller-Esterl W., Wijdenes J., et al. Purification and characterization of the soluble interleukin-6 receptor from human plasma and identification of an isoform generated through alternative splicing. European Journal of Biochemistry 236 (1996) 837-842
45. Mundy G.R. Cytokines and growth factors in the regulation of bone remodeling. Journal of Bone and Mineral Research 8 Suppl. 2 (1993) S505-S510
46. Murakami G., Watabe T., Takaoka K., Miyazono K., and Imamura T. Cooperative inhibition of bone morphogenetic protein signaling by Smurf1 and inhibitory Smads. Molecular Biology the Cell 14 (2003) 2809-2817
47. Nakase T., Takaoka K., Masuhara K., Shimizu K., Yoshikawa H., and Ochi T. Interleukin-1 beta enhances and tumor necrosis factor-alpha inhibits bone morphogenetic protein-2-induced alkaline phosphatase activity in MC3T3-E1 osteoblastic cells. Bone 21 (1997) 17-21
48. Nakashima K., Zhou X., Kunkel G., Zhang Z., Deng J.M., Behringer R.R., et al. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 108 (2002) 17-29
49. Nakashima M., and Reddi A.H. The application of bone morphogenetic proteins to dental tissue engineering. Nature Biotechnology 21 (2003) 1025-1032
50. Nanes M.S. Tumor necrosis factor-alpha: Molecular and cellular mechanisms in skeletal pathology. Gene 321 (2003) 1-15
51. Nohno T., Ishikawa T., Saito T., Hosokawa K., Noji S., Wolsing D.H., et al. Identification of a human type II receptor for bone morphogenetic protein-4 that forms differential heteromeric complexes with bone morphogenetic protein type I receptors. Journal of Biological Chemistry 270 (1995) 22522-22526
52. Noth U., Tuli R., Seghatoleslami R., Howard M., Shah A., Hall D.J., et al. Activation of p38 and Smads mediates BMP-2 effects on human trabecular bone-derived osteoblasts. Experimental Cell Research 291 (2003) 201-211
53. Oates T.W., Xie J.F., Clinton S., Hoang A.M., Graves D.T., and Cochran D.L. PDGF-alpha receptor subunit expression down-regulated by IL-1beta in human periodontal ligament cells. Journal of Dental Research 77 (1998) 1791-1798
54. Philip A., Hannah R., and O'connor-McCourt M. Ectodomain cleavage and shedding of the type III transforming growth factor-beta receptor in lung membranes effect of temperature, ligand binding and membrane solubilization. European Journal of Biochemistry 261 (1999) 618-628
55. Pinckard J.K., Sheehan K.C., Arthur C.D., and Schreiber R.D. Constitutive shedding of both p55 and p75 murine TNF receptors in vivo. Journal of Immunology 158 (1997) 3869-3873
56. Pradel W., Tenbieg P., and Lauer G. Influence of harvesting technique and donor site location on in vitro growth of osteoblastlike cells from facial bone. The International Journal of Oral and Maxillofacial Implants 20 (2005) 860-866
57. Price B.D., and Calderwood S.K. Increased sequence-specific p53-DNA binding activity after DNA damage is attenuated by phorbol esters. Oncogene 8 (1993) 3055-3062
58. Reddi A.H. Bone morphogenetic proteins: An unconventional approach to isolation of first mammalian morphogens. Cytokine & Growth Factor Reviews 8 (1997) 11-20
59. Reddi A.H. Role of morphogenetic proteins in skeletal tissue engineering and regeneration. Nature Biotechnology 16 (1998) 247-252
60. Reddi A.H. Bone morphogenetic proteins and skeletal development: The kidney-bone connection. Pediatric Nephrology 14 (2000) 598-601
61. Reiland J., Ott V.L., Lebakken C.S., Yeaman C., McCarthy J., and Rapraeger A.C. Pervanadate activation of intracellular kinases leads to tyrosine phosphorylation and shedding of syndecan-1. Biochemical Journal 319 (1996) 39-47
62. Rizoli S.B., Rotstein O.D., and Kapus A. Cell volume-dependent regulation of L-selectin shedding in neutrophils. A role for p38 mitogen-activated protein kinase. Journal of Biological Chemistry 274 (1999) 22072-22080
63. Rose-John S., and Heinrich P.C. Soluble receptors for cytokines and growth factors: Generation and biological function. Biochemical Journal 300 (1994) 281-290
64. Rosenzweig B.L., Imamura T., Okadome T., Cox G.N., Yamashita H., ten Dijke P., et al. Cloning and characterization of a human type II receptor for bone morphogenetic proteins. Proceedings of the National Academy of Sciences of the United States of America 92 (1995) 7632-7636
65. Sahin U., Weskamp G., Kelly K., Zhou H.M., Higashiyama S., Peschon J., et al. Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands. Journal of Cell Biology 164 (2004) 769-779
66. Salih V., Knowles J.C., O'Hare M.J., and Olsen I. Retroviral transduction of alveolar bone cells with a temperature-sensitive SV40 large T antigen. Cell and Tissue Research 304 (2001) 371-376
67. Scharla S.H., Strong D.D., Mohan S., Chevalley T., and Linkhart T.A. Effect of tumor necrosis factor-alpha on the expression of insulin-like growth factor I and insulin-like growth factor binding protein 4 in mouse osteoblasts. European Journal of Endocrinology 131 (1994) 293-301
68. Seger R., and Krebs E.G. The MAPK signaling cascade. The FASEB Journal 9 (1995) 726-735
69. Shimizu T., Mehdi R., Yoshimura Y., Yoshikawa H., Nomura S., Miyazono K., et al. Sequential expression of bone morphogenetic protein, tumor necrosis factor, and their receptors in bone-forming reaction after mouse femoral marrow ablation. Bone 23 (1998) 127-133
70. Spinella-Jaegle S., Roman-Roman S., Faucheu C., Dunn F.W., Kawai S., Gallea S., et al. Opposite effects of bone morphogenetic protein-2 and transforming growth factor-beta1 on osteoblast differentiation. Bone 29 (2001) 323-330
71. Takagi M., Absalon M.J., McLure K.G., and Kastan M.B. Regulation of p53 translation and induction after DNA damage by ribosomal protein L26 and nucleolin. Cell 123 (2005) 49-63
72. Tamura Y., Takeuchi Y., Suzawa M., Fukumoto S., Kato M., Miyazono K., et al. Focal adhesion kinase activity is required for bone morphogenetic protein--Smad1 signaling and osteoblastic differentiation in murine MC3T3-E1 cells. Journal of Bone and Mineral Research 16 (2001) 1772-1779
73. Ten Dijke P., Fu J., Schaap P., and Roelen B.A.J. Signal Transduction of Bone Morphogenetic Proteins in Osteoblast Differentiation. Journal of Bone and Joint Surgery 85 (2003) 34-38
74. Ten Dijke P., Yamashita H., Sampath T.K., Reddi A.H., Estevez M., Riddle D.L., et al. Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4. Journal of Biological Chemistry 269 (1994) 16985-16988
75. Umata T., Hirata M., Takahashi T., Ryu F., Shida S., Takahashi Y., et al. A dual signaling cascade that regulates the ectodomain shedding of heparin-binding epidermal growth factor-like growth factor. Journal of Biological Chemistry 276 (2001) 30475-30482
76. Van der Horst G., van Bezooijen R.L., Deckers M.M., Hoogendam J., Visser A., Lowik C.W., et al. Differentiation of murine preosteoblastic KS483 cells depends on autocrine bone morphogenetic protein signaling during all phases of osteoblast formation. Bone 31 (2002) 661-669
77. Vecchi M., Baulida J., and Carpenter G. Selective cleavage of the heregulin receptor ErbB-4 by protein kinase C activation. Journal of Biological Chemistry 271 (1996) 18989-18995
78. Vecchi M., and Carpenter G. Constitutive proteolysis of the ErbB-4 receptor tyrosine kinase by a unique, sequential mechanism. Journal of Cell Biology 139 (1997) 995-1003
79. Vecchi M., Rudolph-Owen L.A., Brown C.L., Dempsey P.J., and Carpenter G. Tyrosine phosphorylation and proteolysis. Pervanadate-induced, metalloprotease-dependent cleavage of the ErbB-4 receptor and amphiregulin. Journal of Biological Chemistry 273 (1998) 20589-20595
80. Yabkowitz R., Meyer S., Black T., Elliott G., Merewether L.A., and Yamane H.K. Inflammatory cytokines and vascular endothelial growth factor stimulate the release of soluble tie receptor from human endothelial cells via metalloprotease activation. Blood 93 (1999) 1969-1979
81. Yagi K., Tsuji K., Nifuji A., Shinomiya K., Nakashima K., DeCrombrugghe B., et al. Bone morphogenetic protein-2 enhances osterix gene expression in chondrocytes. Journal of Cellular Biochemistry 88 (2003) 1077-1083
82. Yamaguchi A., Komori T., and Suda T. Regulation of osteoblast differentiation mediated by bone morphogenetic proteins, hedgehogs, and Cbfa1. Endocrine Reviews 21 (2000) 393-411
83. Zhang W., and Liu H.T. MAPK signal pathways in the regulation of cell proliferation in mammalian cells. Cell Research 12 (2002) 9-18
84. Zhao M., Qiao M., Harris S.E., Oyajobi B.O., Mundy G.R., and Chen D. Smurf1 inhibits osteoblast differentiation and bone formation in vitro and in vivo. Journal of Biological Chemistry 279 (2004) 12854-12859